The below information on Reyataz has been taken from official FDA sources, but we cannot guarantee it's accuracy. Please use this site for educational purposes only. This site does not replace a proper discussion with your doctor.
|This drug was approved by the FDA in one form or another on:|
|This drug is made in one form or another by the following companies:|
|This drug is available in the following forms:|
|View the actual FDA approved label for this drug at the following links:|
Reyataz is a prescription medicine used with other anti-HIVmedicines to treat people who are infected with the humanimmunodeficiency virus (HIV). Reyataz is a type of anti-HIV medicinecalled a protease inhibitor. Reyataz helps to block HIV protease, anenzyme that is needed for the HIV virus to multiply. Reyataz maylower the amount of HIV in your blood, help your body keep itssupply of CD4 (T) cells, and reduce the risk of death and illnessassociated with HIV.
Reyataz does not cure HIV infection or AIDS. People takingReyataz may still get opportunistic infections or other conditionsthat happen with HIV infection. It is very important that you seeyour healthcare provider regularly while taking Reyataz.
Even if you are taking Reyataz, you may still pass HIV to otherpeople through sexual contact, sharing needles, or being exposed toyour blood. For your health and the health of others, it isimportant to always practice safer sex and never use or share dirtyneedles.
Precautions for Reyataz
- Reyataz may cause an increase in bilirubin levels in the blood (bilirubin is made by the liver). This may cause your skin or the white part of your eyes to turn yellow.
- Reyataz may cause a change in the way your heart beats (heart rhythm change). Signs and symptoms include dizziness or lightheadedness.
- Reyataz may cause diabetes and high blood sugar. Some patients may need changes in their diabetes medicine.
- If you have liver disease including hepatitis B or C, your liver disease may get worse when you take anti-HIV medicines like Reyataz.
- Some people with hemophilia have reported increased bleeding problems while taking protease inhibitors like Reyataz.
- Lactic acidosis syndrome (a severe buildup of acid in the blood that sometimes causes death) has been reported in patients taking Reyataz along with anti-HIV medicines called nucleoside analogues. Lactic acidosis syndrome has happened more in people who are female or very overweight. Lactic acidosis syndrome is a medical emergency and must be treated in the hospital. The following are signs of lactic acidosis syndrome: persistent nausea, vomiting or unexpected stomach discomfort; weakness and tiredness; trouble breathing; and weakness especially in the arms and legs.
- Use of antiretroviral medications, including Reyataz, has been associated with changes in body fat. These changes may include an increased amount of fat in the upper back and neck (“buffalo hump”), breast, and around the trunk. Loss of fat from the legs, arms, and face may also happen.
Side Effects of Reyataz
Common side effects with Reyataz when taken with other anti-HIV medicines include:
- stomach pain
- trouble sleeping
- tingling or burning of hands and feet
- muscle pain
- yellowing of skin or white part of eye
Who Should Not Take Reyataz
Do not take Reyataz if you are:
- taking certain medications. Serious life-threatening side effects or death may happen when taking certain medications with Reyataz. Before you take Reyataz, tell your healthcare provider about all medicines you are taking or planning to take. These include other prescription and nonprescription medicines, vitamins, and herbal supplements.
- allergic to Reyataz or any of its ingredients.
Recent Forum Posts on Reyataz
Site Copyright © 2003-2008 Jalic Inc. All rights reserved.